Higher efficacy and reduced adverse reactions in neoadjuvant chemotherapy for breast cancer by using pegylated liposomal doxorubicin compared with pirarubicin

por Weifang Liu, Wei Chen, Xiuxiang Zhang, Peng Zhao, Zhimin Fan, Lirong Bi, Di Wu, Sijie Li, Ming Yang, Tong Fu, Dong Song, Bing Han, Gang Zhao, Ye Du, Aiping Shi
Publicado 2021